- Recent Funding
- Investors
- Leaps by Bayer
Leaps by Bayer portfolio
Leaps by Bayer has 5 portfolio companies on record at Recent Funding. Its most recent investment on record is Huma Therapeutics's $80M Series B+ round in July 2024, alongside Hitachi Ventures, HAT Sicaf and AstraZeneca. By category, its portfolio leans toward Health and bio (5) and AI agents (1). It has co-invested with General Catalyst, Threshold Ventures and Merck Global Health Innovation Fund, most often General Catalyst (2 rounds).
What Leaps by Bayer invests in
- Health and bio · 5 · 100%
- AI agents · 1 · 20%
- Data and analytics · 1 · 20%
- HR and recruiting · 1 · 20%
- Commerce and retail · 1 · 20%
Leaps by Bayer recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $80M | Hitachi Ventures, HAT Sicaf, AstraZeneca | ||
| Series B+ · $126M | Threshold Ventures, Merck Global Health Innovation Fund, Memorial Hermann Health System +6 | ||
| Series B+ · $58M | Threshold Ventures, Merck Global Health Innovation Fund, Kleiner Perkins +5 |
How Leaps by Bayer invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 3 100% | $264M |
Share is of the 3 rounds on Recent Funding that name Leaps by Bayer. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Leaps by Bayer portfolio companies
HHuma Therapeutics$80MSeries B+ · Jul 2024
TTranscarent$126MSeries B+ · May 2024
AAndesbacker
CCelea Therapeuticsbacker
OOne Biobacker
| Company | Round with Leaps by Bayer | Total raised | Latest raise |
|---|---|---|---|
AI agents |
Series B+ · $80M | $118M | Sep 11, 2024 round |
Health and bio |
Series B+ · $126M | $384M | May 2, 2024 Series B+ |
Health and bio |
backer | $30M | Jan 9, 2026 Seed |
Health and bio |
backer | $180M | Jul 2, 2026 Series A |
Health and bio |
backer | $27M | Dec 11, 2024 Series A |
Most frequent co-investors
GGeneral Catalyst2 shared rounds · last May 2, 2024
TThreshold Ventures2 shared rounds · last May 2, 2024
MMerck Global Health Innovation Fund2 shared rounds · last May 2, 2024
AAlta Partners2 shared rounds · last May 2, 2024
HHitachi Ventures1 shared round · last Jul 16, 2024
AAstraZeneca1 shared round · last Jul 16, 2024
HHAT Sicaf1 shared round · last Jul 16, 2024
GGeodesic Capital1 shared round · last May 2, 2024
HHuman Capital1 shared round · last May 2, 2024
AAlly Bridge Group1 shared round · last May 2, 2024
KKinnevik1 shared round · last May 2, 2024
MMemorial Hermann Health System1 shared round · last May 2, 2024
Similar investors
DDecheng Capital5 companies · 3 deals in 12 mo
MMaverick Ventures5 companies · 3 deals in 12 moMMMC Ventures5 companies · 3 deals in 12 mo
RRegeneron Ventures5 companies · 3 deals in 12 mo
TThe Venture Collective5 companies · 3 deals in 12 mo
BBlack Opal Ventures5 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Leaps by Bayer, which is a subset of its real portfolio. API: /api/v1/investors/leaps-by-bayer (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy